Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette-Guérin.

× No keyword cloud information.

6 in total

1. Transfer factor therapy in ataxia--telangiectasia.

Authors: A I Berkel; F Ersoy; L B Epstein; L E Spitler
Journal: Clin Exp Immunol Date: 1977-09 Impact factor: 4.330

2. Transfer factor: a potential agent for immunotherapy of cancer.

Authors: C R Meier; A F LoBuglio
Journal: World J Surg Date: 1977-09 Impact factor: 3.352

3. Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Authors: Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal: Oncoimmunology Date: 2012-09-01 Impact factor: 8.110

Review 4. Melanoma: adjuvant therapy and other treatment options.

Authors: Alicia Terando; Michael S Sabel; Vernon K Sondak
Journal: Curr Treat Options Oncol Date: 2003-06

5. Immunological monitoring in a controlled trial of immunotherapy in stage IIB malignant melanoma.

Authors: M J Embleton; J H Ransom; M B McIllmurray; W G Reeves
Journal: Br J Cancer Date: 1978-04 Impact factor: 7.640

6. IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production.

Authors: Ana Carolina Martínez-Torres; Alejandra Reyes-Ruiz; Milena Benítez-Londoño; Moises Armides Franco-Molina; Cristina Rodríguez-Padilla
Journal: BMC Cancer Date: 2018-01-03 Impact factor: 4.430

6 in total